GlaxoSmithKline Presents Innovative Neuroscience Pipeline (The San Francisco Examiner)
PHILADELPHIA and LONDON , Dec. 13 /PRNewswire-FirstCall/ -- GlaxoSmithKline (GSK) plc today presented an overview of its neuroscience portfolio and the company's disease area strategy to investors and analysts at a meeting in New York.

MicroIslet Holds Positive Pre-IND Meeting for US Based Human Clinical Trial With FDA (FinanzNachrichten)
MicroIslet, ( Nachrichten ) Inc. (MIIS.OB, http://www.microislet.com ), a biotechnology company engaged in the development and commercialization of transplantation therapies for diabetes, announced that it has met with the U.S. Food and Drug Administration (FDA) to discuss requirements for the filing of an Investigational New Drug (IND) application for MicroIslet-P , a microencapsulated ...

FDA Gives Stomach Drugs Prilosec And Nexium The Thumbs Up (Medical News Today)
Further to its preliminary review in August, when it gave the drugs a provisional go ahead, the US Food and Drug Administration (FDA) has conducted a further review of clinical studies on the safety of AstraZeneca stomach drugs Prilosec (generic name omeprazole) and Nexium (generic name esomepra [click link for full article]